Immediate Impact

51 standout
Sub-graph 1 of 22

Citing Papers

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
2024 Standout
AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
2024 Standout
7 intermediate papers

Works of Lourens Bester being referenced

Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of This Novel Treatment Option
2009
Radioembolization with 90Y Microspheres: Angiographic and Technical Considerations
2007
and 2 more

Author Peers

Author Last Decade Papers Cites
Lourens Bester 814 490 532 584 41 1.4k
Armeen Mahvash 978 585 471 489 74 1.5k
Khairuddin Memon 1213 530 444 390 25 1.5k
Philipp M. Paprottka 521 481 477 329 76 1.3k
Rodolfo Núñez 398 346 651 487 37 1.5k
Michaël Vouche 1185 576 335 235 46 1.5k
Nadia Russolillo 1025 819 380 839 70 1.5k
Janio Szklaruk 513 239 280 193 34 1.0k
S Zangos 545 304 325 316 41 1.3k
Reena Jha 392 336 276 334 48 1.6k
A. K. C. Li 527 974 480 364 62 1.5k

All Works

Loading papers...

Rankless by CCL
2026